Cargando…
Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age
BACKGROUND: The Oncotype DX 21-gene Recurrence Score is a genomic-based algorithm that guides adjuvant chemotherapy treatment decisions for women with early-stage, oestrogen receptor (ER)-positive breast cancer. However, there are age-related differences in chemotherapy benefit for women with interm...
Autores principales: | Bernhardt, Sarah M., Dasari, Pallave, Wrin, Joseph, Raymond, Wendy, Edwards, Suzanne, Walsh, David, Townsend, Amanda R., Price, Timothy J., Ingman, Wendy V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437067/ https://www.ncbi.nlm.nih.gov/pubmed/32811558 http://dx.doi.org/10.1186/s13058-020-01327-1 |
Ejemplares similares
-
Ovarian cycle stage critically affects 21-gene recurrence scores in Mmtv-Pymt mouse mammary tumours
por: Bernhardt, Sarah M., et al.
Publicado: (2021) -
Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women
por: Bernhardt, Sarah M., et al.
Publicado: (2016) -
Timing of breast cancer surgery during the menstrual cycle-is there an optimal time of the month?
por: Bernhardt, Sarah M., et al.
Publicado: (2020) -
Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk
por: Atashgaran, Vahid, et al.
Publicado: (2016) -
Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk
por: Archer, Maddison, et al.
Publicado: (2021)